• 9 Oct 2025

Dr Jordan Fletcher

With over 20 years of experience in peptide-based research, Jordan brings deep expertise in the design, synthesis, characterization, and biophysical analysis of peptides. Originally trained as a pharmacologist, his work has spanned drug development, synthetic biology, and fundamental peptide assembly. Jordan has excelled in both academic and industrial environments, including a key role in spinning out Rosa Biotechnology, where peptide-based differential sensors were developed to detect disease. His broad skill set and proven leadership make him a vital asset to any peptide-focused initiative.

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders